Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

EcPLA

From Wikipedia, the free encyclopedia
(Redirected fromEthylcyclopropyllysergamide)
Chemical compound

Pharmaceutical compound
EcPLA
Clinical data
Other namesECYPLA;N-Ethyl-N-cyclopropyllysergamide
Routes of
administration
Oral
Drug classSerotonin receptor modulator;Serotonin 5-HT2A receptor agonist;Serotonergic psychedelic;Hallucinogen
Legal status
Legal status
Identifiers
  • (6aR,9R)-N-cyclopropyl-N-ethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChemCID
ChemSpider
Chemical and physical data
FormulaC21H25N3O
Molar mass335.451 g·mol−1
3D model (JSmol)
  • CCN(C1CC1)C(=O)[C@@H]3C=C2c4cccc5ncc(C[C@H]2N(C)C3)c45
  • InChI=1S/C21H25N3O/c1-3-24(15-7-8-15)21(25)14-9-17-16-5-4-6-18-20(16)13(11-22-18)10-19(17)23(2)12-14/h4-6,9,11,14-15,19,22H,3,7-8,10,12H2,1-2H3/t14-,19-/m1/s1
  • Key:UNUJKEQFYPYXBK-AUUYWEPGSA-N

EcPLA, also known asN-ethyl-N-cyclopropyllysergamide, is apsychedelic drug of thelysergamide family related tolysergic acid diethylamide (LSD).[2][3] It is anisomer ofLSZ and is closely related to otheramide-substituted lysergamides likeMiPLA.[3][2][4]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]

EcPLA has been found to interact withserotonin receptors anddopamine receptors, among othertargets.[3] It is apotencyagonist of theserotonin5-HT2A,5-HT2B, and5-HT2C receptors.[3]

The drug produces thehead-twitch response, a behavioral proxy ofpsychedelic effects, in rodents.[3] It has about 40% of the potency of LSD in this regard.[3]

Pharmacokinetics

[edit]

Thein-vitrometabolism of EcPLA has been studied.[5]

Chemistry

[edit]

Analogues

[edit]

Analogues of EcPLA includeMiPLA,LAMPA (MPLA),EPLA,EiPLA,ETFELA, andLSZ, among others.[4][3][2]

History

[edit]

EcPLA was first described in thescientific literature by a team that includedAdam Halberstadt,Alexander Stratford,Jason Wallach, andDavid E. Nichols in 2019.[3] It was developed byLizard Labs.[citation needed]

See also

[edit]

References

[edit]
  1. ^"Arrêté du 20 mai 2021 modifiant l'arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants".www.legifrance.gouv.fr (in French). 20 May 2021.
  2. ^abcKavanagh PV, Westphal F, Stratford A, Elliott SP, Dowling G, Halberstadt AL, et al. (2020)."Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ)".Drug Testing and Analysis.12 (10):1514–1521.doi:10.1002/dta.2911.ISSN 1942-7611.PMC 9191644.PMID 32803833.
  3. ^abcdefghHalberstadt AL, Klein LM, Chatha M, Valenzuela LB, Stratford A, Wallach J, et al. (February 2019)."Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)".Psychopharmacology.236 (2):799–808.doi:10.1007/s00213-018-5055-9.PMC 6848745.PMID 30298278.
  4. ^abWachełko O, Nowak K, Tusiewicz K, Zawadzki M, Szpot P (January 2025). "A highly sensitive UHPLC-MS/MS method for determining 15 designer LSD analogs in biological samples with application to stability studies".Analyst.150 (2):290–308.doi:10.1039/d4an01361a.PMID 39636448.
  5. ^Wagmann L, Richter LH, Kehl T, Wack F, Bergstrand MP, Brandt SD, et al. (July 2019)."In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures"(PDF).Analytical and Bioanalytical Chemistry.411 (19):4751–4763.doi:10.1007/s00216-018-1558-9.PMID 30617391.S2CID 58615418.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
Ergolines
(incl.lysergines)
Clavines
(6,8-dimethylergolines)
Lysergamides
(lysergic acid amides)
Ergopeptines
(peptide ergolines)
Partial ergolines
Related compounds
Natural sources
Retrieved from "https://en.wikipedia.org/w/index.php?title=EcPLA&oldid=1318171104"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp